12 results

Financial information Group

Ipsen delivers encouraging sales growth in Q1, confirms full-year guidance

We are pleased to announce encouraging sales growth of 5.5% at CER (0.6% as reported)…

Group People

Ipsen announces the arrival of Gwenan White, EVP Communications & Public Affairs

We are pleased to announce the arrival of Gwenan White as Executive Vice President, Communications…

Financial information Group

FY2020 financial results

In the face of the profound challenges and disruptions linked to the COVID-19 pandemic in…

Group Rare diseases

Why 2021 is the year for R&D progress

By Howard Mayer, M.D. - Executive Vice President, Head of Research and Development 2020…

CSR Group

Ipsen and the fight against corruption

Today is International Anti-Corruption Day. We are all aware that corruption has the potential to…

Event Group

Ipsen’s new strategic priorities unveiled at virtual Capital Markets Day event

Today, Ipsen is hosting a virtual Capital Markets Day to launch our new Group strategy…

Event Group

Ipsen – Capital Markets Day Webcast – Tuesday, December 1, 2020

David Loew, Chief Executive Officer, is pleased to host a Capital Markets Day webcast…


Ipsen – Q3 2020 Sales Conference Call – Thursday, October 22, 2020

David Loew, Chief Executive Officer, is pleased to host a conference call to discuss the…


Ipsen announces sales growth over the first 9 months of 2020

Around the world, COVID-19 cases are on the rise again. Despite the challenges presented by…


Ipsen announces the appointment of new EVP Business Development

September 25, 2020

We are pleased to announce that our Business Development team will be led by Philippe…


Executive Leadership Team Announcement

We are pleased to announce the appointment of Bartek Bednarz, Executive Vice President Global Product…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2021